enVVeno Medical (NASDAQ:NVNO) reported quarterly losses of $(6.05) per share which missed the analyst consensus estimate of $(0.30) by 1916.67 percent. This is a 42.38 percent increase over losses of $(10.50) per share from the same period last year.